In this study, we leveraged the synergistic strengths of scRNA-seq and bulk transcriptomics to systematically investigate glycolytic dysregulation in PCOS, identifying PLK2 as a key regulatory gene in endothelial cell glycolysis and cell-cell communication. This evidence concerns the gene PLK2 and polycystic ovary syndrome.